drugset
drugset / Press release

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies

2014-12-22 · MacroGenics · original macrogenics.com ↗

Duvortuxizumab

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies 21.3 KB

The release as fetched from its publisher. macrogenics.com ↗